New treatment for Huntington’s disease

Israeli biotech Mitoconix Bio is developing a new treatment for Huntington’s disease and other neurodegenerative disorders. It works by inhibiting mitochondrial splitting. Mitochondria contribute to important brain functions, including regulation of cell growth.

http://www.timesofisrael.com/israeli-startup-takes-aim-at-huntingtons-disease/

http://www.futurx.co.il/portfolio/mitoconix-bio/

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *